PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
125.64%
Net income growth above 1.5x CRK's 64.27%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
5.16%
Some D&A expansion while CRK is negative at -100.00%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
7.46%
Lower deferred tax growth vs. CRK's 383.74%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
No Data
No Data available this quarter, please select a different quarter.
61.49%
Slight usage while CRK is negative at -80.35%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
61.49%
Some yoy usage while CRK is negative at -698.39%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-129.91%
Negative yoy while CRK is 790.84%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
52.13%
Operating cash flow growth above 1.5x CRK's 31.51%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
12.91%
Some CapEx rise while CRK is negative at -10.28%. John Neff would see competitor possibly building capacity while we hold back expansions.
-182.44%
Negative yoy acquisition while CRK stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
131.88%
Purchases growth of 131.88% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-12.91%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
3.41%
We have some outflow growth while CRK is negative at -64.71%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
1.11%
We have mild expansions while CRK is negative at -30.62%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
4.08%
Debt repayment well below CRK's 100.00%. Michael Burry suspects heavier leverage risk or insufficient cash generation to keep pace.
-100.00%
Negative yoy issuance while CRK is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
No Data
No Data available this quarter, please select a different quarter.